← All trials
NCT05696366
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 28, 2023
- Primary completion
- Jan 31, 2026
- Completion date
- Jan 31, 2026
- First posted
- Jan 25, 2023
- Last posted
- Jan 25, 2023
- Enrollment
- 22
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of California, San DiegoLead sponsor
- University of California, San DiegoReponsible party - principal investigator
- Juvenile Diabetes Research FoundationCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.